Under the direction of Martin J. Edelman, MD, Chair, Department of Hematology/Oncology, who joined Fox Chase Cancer Center earlier this year, the department has been reorganized into four sections: Hematologic Malignancies, Solid Tumor Oncology, General Hematology/Oncology, and Fox Chase at Temple University Hospital.
Along with the reorganization, Fox Chase has announced several new faculty and appointments within the Department of Hematology/Oncology and within the Cancer Center.
Deric Savior, MD, Head, Medical Oncology
In line with the reorganization, Deric Savior, MD, has been appointed Head of Medical Oncology at Fox Chase Cancer Center at Temple University Hospital. In his new role, Dr. Savior will take the lead in expanding medical oncology services at the hospital.
Deric Savior, MD
Dr. Savior specializes in treating lung and head and neck cancers. Previously, he led the Fox Chase Thoracic Oncology Section at Temple University Hospital. He has also been a faculty advisor to the Student National Medical Association/Latino Medical Association and Hematology/Oncology Interest Group at Temple University’s Lewis Katz School of Medicine.
As Chief, one of his top priorities will be strengthening cancer research efforts, especially enrolling more patients in the many clinical trials underway at both Fox Chase and Temple University Hospital.
Emmanuel T. Quien, MD, and Carlyn Tan, MD, Join Department of Hematology/Oncology
Emmanuel T. Quien, MD
Emmanuel T. Quien, MD, recently joined the Department of Hematology/Oncology, beginning in his new role as Associate Professor at Fox Chase on August 1, 2017. Dr. Quien is a board-certified hematologist and medical oncologist who has been working within the Temple University Health System for nearly 20 years. Dr. Quien will continue to provide clinical services at the Temple Health Northeastern Ambulatory Care campus as well as on-site and on-call support to the hematology program at Jeanes Hospital.
Dr. Quien comes to Fox Chase from Temple University Hospital and Temple Physicians, Inc. He earned his medical degree from the University of Santo Tomas in his native Philippines and completed a residency in internal medicine and a fellowship in hematology/oncology at the University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School.
Carlyn Tan, MD
Carlyn Tan, MD, has joined the Department of Hematology/Oncology -following a 3-year fellowship in hematology/oncology performed at Fox Chase Cancer Center/Temple University. Dr. Tan earned her medical degree from Albert Einstein College of Medicine.
Dr. Tan is board certified in internal medicine and board eligible in hematology and medical oncology. She began her new role at Fox Chase on August 15, 2017.
Alexander Kutikov, MD, Appointed Chief of Urologic Oncology
Alexander Kutikov, MD, has been appointed Chief of the Division of Urologic Oncology. Dr. Kutikov is Professor of Surgical Oncology at Fox Chase. He is a board-certified, academic urologic surgical oncologist who treats urologic tumors using minimally invasive (robotic/laparoscopic) and traditional surgical techniques.
Alexander Kutikov, MD
Dr. Kutikov earned his medical degree at Harvard Medical School and completed his residency in urology at the University of Pennsylvania.
Dr. Kutikov will fill the role being vacated by Richard Greenberg, MD, who served as Chief of the Division of Urology and Urologic Oncology for 22 years. Dr. Greenberg will continue his full clinical responsibilities and serve as Professor of Urology at both Fox Chase and the Lewis Katz School of Medicine at Temple University.
Dr. Kutikov joined the Department of Surgical Oncology at Fox Chase in 2010 after completing a Society of Urologic Oncology fellowship at the Center.
Reza Nejati, MD, Joins Department of Pathology
Reza Nejati, MD
Reza Nejati, MD, recently joined the Department of Pathology as a hematopathologist. Dr. Nejati comes to Fox Chase from the University of Pennsylvania, where he completed a fellowship in hematopathology.
He received his medical degree from Tehran University of Medical Sciences in Iran and completed his residency training in anatomic and clinical pathology at both Iran University of Medical Sciences and the University of Tennessee Health Science Center. Dr. Nejati completed a surgical pathology fellowship at MD Anderson Cancer Center and is board certified in anatomic and clinical pathology.
“Dr. Nejati brings a depth of knowledge and international scope that will benefit our team here at Fox Chase,” said Arthur Patchefsky, MD, Chair of the Department of Pathology. ■
